E8-20579. Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Veterinary Feed Directive  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

    DATES:

    Fax written comments on the collection of information by October 6, 2008.

    ADDRESSES:

    To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, FAX: 202-395-6974, or e-mailed to baguilar@omb.eop.gov. All comments should be identified with the OMB control number 0910-0363. Also include the FDA docket number found in brackets in the heading of this document.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Denver Presley, Jr., Office of Information Management (HFA-710), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-796-3793.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance.

    Veterinary Feed Directive—21 CFR Part 558 (OMB Control Number 0910-0363)—Extension

    With passage of the Animal Drug Availability Act, Congress enacted legislation establishing a new class of restricted feed use drugs called Veterinary Feed Directive (VFD) drugs. The VFD class of drugs may be distributed without involving State pharmacy laws. Although controls on the distribution and use of VFD drugs are similar to controls for prescription drugs regulated under section 503(f) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 503(f)), the implementing VFD regulation under section 558.6 (21 CFR 558.6) is tailored to the unique circumstances relating to the distribution of medicated feeds. The content of the VFD is spelled out in the regulation. All distributors of medicated feed containing VFD drugs must notify FDA of their intent to distribute, and the distribution records of all medicated feeds containing VFD must be maintained. The VFD regulation ensures the protection of the public health while enabling animal producers to obtain and use needed drugs as efficiently and cost-effectively as possible.

    In the Federal Register of June 5, 2008 (73 FR 32029), FDA published a 60-day notice requesting public comment on the information collection provisions. No comments were received.

    FDA estimates the burden for this collection of information as follows:

    Table 1.—Estimated Annual Reporting Burden1

    21 CFR SectionNo. of RespondentsAnnual Frequency per ResponseTotal Annual ResponsesHours per ResponseTotal Hours
    558.6(a)(3) through (a)(5)15,00025375,000.2593,750
    558.6(d)(1)(i) through (d)(1)(iii)3001300.2575
    558.6(d)(1)(iv)20120.255
    558.6(d)(2)1,00055,000.251,250
    514..1(b)(9)1113.003
    Total16,32195,083
    1 There are no capital costs or operating and maintenance costs associated with this collection of information.

    Table 2.—Estimated Annual Recordkeeping Burden1

    21 CFR SectionNo. of RecordkeepersAnnual Frequency per RecordkeepingTotal Annual RecordsHours per RecordTotal Hours
    558.6(c)(1) through (c)(4)112,500101,125,000.016718,788
    558.6(e)(1) through (e)(4)5,00075375,000.01676,263
    Total117,50025,051
    1 There are no capital costs or operating and maintenance costs associated with this collection of information.
    Start Signature
    Start Printed Page 51823

    Dated: August 28, 2008.

    Jeffrey Shuren,

    Associate Commissioner for Policy and Planning.

    End Signature End Supplemental Information

    [FR Doc. E8-20579 Filed 9-4-08; 8:45 am]

    BILLING CODE 4160-01-S

Document Information

Comments Received:
0 Comments
Published:
09/05/2008
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
E8-20579
Dates:
Fax written comments on the collection of information by October 6, 2008.
Pages:
51822-51823 (2 pages)
Docket Numbers:
Docket No. FDA-2005-N-0474
PDF File:
e8-20579.pdf